Background and aims Very little is known about the access to treatment for Chronic Hepatitis B in the real clinical practice and the characteristics of the patients who do not receive antiviral therapy. Methods HBV-RER is an observational multicenter network that collected data of patients with HBV infection during a 3 years observational period (2009–2012). Results Among 2527 HBsAg positive patients, 1099 were never treated (NT); only 280 were included in the analysis due to different exclusion causes A minority was HBeAg-positive. The median age was 42. At liver biopsy most patients had Metavir score of F0-F1. Univariate analysis between 280 NT patients and the 290 naïve to treatment showed that NT patients were mostly female (P = 0.002), not Italian (P = 0.044), younger (P < 0.001). Metavir score was lower in NT (P0.002), such as the Fib4 score (P < 0.001). HBV DNA level was significantly higher in NT. At multivariate analysis, independent variables associated with no-treatment were younger age, female gender, Metavir score F0-F1, Fib4 lower than 1.6 and lower blood level of HBV-DNA. Conclusions There is a large number of patients eligible to treatment who do not receive it. A younger age and a less severe disease seem to be associated to deferral of treatment.
Missed treatment in an Italian HBV infected patients cohort: HBV RER / Cuomo, Gianluca; Borghi, Vanni; Andreone, Pietro; Massari, Marco; Villa, Erica; Pietrangelo, Antonello; Verucchi, Gabriella; Ferrari, Carlo; Ferrari, C.; Giuberti, T.; Villa, E.; Andreone, P.; Pietrangelo, A.; Abbati, G.; Magnani, G.; Massari, M.; Verucchi, G.; Cancellieri, C.; Ricca Rosellini, S.; Levantesi, F.; Mazzella, G.; Sacchini, D.; Fornaciari, G.; Mussini, C.; Borghi, V.; Foschi, F.; Libanore, M.; Carradori, S. D.; Contini, C.; Ballardini, G.; Macchia, S.; Boccia, S.; Vandelli, C.; Bassi, P.; Zanotti, M.; Loria, P.; Sbolli, G.; Fornari, F.; di Maira, P. V.; Bellentani, S.; Arlotti, M.; Grosso, C.; Bolondi, G.; Pazzi, P.; Mazzocchi, A.; Govoni, A.; Fusaroli, P.; Giacomoni, P. L.; Lenzi, M.; Pedretti, G.. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 48:11(2016), pp. 1346-1350. [10.1016/j.dld.2016.07.016]
Missed treatment in an Italian HBV infected patients cohort: HBV RER
FERRARI, Carlo;
2016-01-01
Abstract
Background and aims Very little is known about the access to treatment for Chronic Hepatitis B in the real clinical practice and the characteristics of the patients who do not receive antiviral therapy. Methods HBV-RER is an observational multicenter network that collected data of patients with HBV infection during a 3 years observational period (2009–2012). Results Among 2527 HBsAg positive patients, 1099 were never treated (NT); only 280 were included in the analysis due to different exclusion causes A minority was HBeAg-positive. The median age was 42. At liver biopsy most patients had Metavir score of F0-F1. Univariate analysis between 280 NT patients and the 290 naïve to treatment showed that NT patients were mostly female (P = 0.002), not Italian (P = 0.044), younger (P < 0.001). Metavir score was lower in NT (P0.002), such as the Fib4 score (P < 0.001). HBV DNA level was significantly higher in NT. At multivariate analysis, independent variables associated with no-treatment were younger age, female gender, Metavir score F0-F1, Fib4 lower than 1.6 and lower blood level of HBV-DNA. Conclusions There is a large number of patients eligible to treatment who do not receive it. A younger age and a less severe disease seem to be associated to deferral of treatment.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
